Why Farbe Firma is the Top Manufacturer of Meldonium Injection
- Maulik Sudani
- 11 hours ago
- 6 min read
Last Updated: June 6, 2026
TL;DR: Meldonium Injection — a sterile aqueous solution of the cardiometabolic anti-ischaemic agent meldonium (mildronate; trimethylhydrazinium propionate), supplied most commonly as a 100 mg/mL solution in 5 mL ampoules (500 mg) for intravenous or intramuscular administration — is a widely used agent in ischaemic and cardiometabolic disorders: stable and unstable angina, chronic heart failure, the rehabilitation phase after myocardial infarction, and cerebrovascular ischaemia. Meldonium works by reversibly inhibiting gamma-butyrobetaine hydroxylase and limiting carnitine biosynthesis and transport, shifting cellular energy metabolism away from fatty-acid oxidation toward more oxygen-efficient glucose oxidation, so ischaemic tissue tolerates reduced oxygen supply better. Because the parenteral dose must be exact, sterile and particulate-free, its safety depends on a precise stability-indicating assay, a tightly controlled impurity profile, low particulate and endotoxin, correctly held pH and robust ampoule container-closure integrity. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Meldonium Injection at our Gujarat, India facility and supplies it to hospital pharmacy, cardiology, neurology and critical-care services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Cardiometabolic / anti-ischaemic agent — Meldonium Injection is used in angina, chronic heart failure, post-myocardial-infarction rehabilitation and cerebrovascular ischaemia, shifting cellular metabolism from fatty-acid oxidation toward oxygen-efficient glucose oxidation by inhibiting gamma-butyrobetaine hydroxylase and limiting carnitine biosynthesis.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified ampoule filling lines, dedicated control of the stability-indicating assay, the impurity profile, pH, particulate and endotoxin for a sterile aqueous injection, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready ampoule packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Meldonium Injection Demands a Premium Manufacturer
Meldonium Injection occupies a well-established place in cardiology and neurology across many markets. It is the parenteral cardiometabolic agent that clinicians reach for to support ischaemic tissue — in stable and unstable angina, in chronic heart failure, during rehabilitation after a myocardial infarction, and in cerebrovascular ischaemia — when the goal is to help cells make better use of a limited oxygen supply. Given by intravenous or intramuscular injection, it shifts cellular energy production toward more oxygen-efficient glucose oxidation. In each of these settings the patient may have compromised circulation, the clinician needs a predictable and reproducible response, and the dose delivered from each ampoule must be accurate, sterile and reliably the same from unit to unit.
That clinical reality places real demands on the manufacturer. Meldonium is a highly water-soluble, hygroscopic small molecule whose injectable solution must stay clear, correctly potent and free of degradation products across its shelf life. The assay must be exact; the impurity and degradation profile must stay within tight limits; the solution must be particulate-free, low in endotoxin, held at the right pH for tolerability and sealed in an ampoule whose integrity is verified. Choosing a Meldonium Injection manufacturer that treats the stability-indicating assay, impurity profiling, pH control, particulate and endotoxin control and container-closure integrity as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Meldonium Injection Manufacturer Apart
A world-class manufacturer of Meldonium Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of meldonium together with tight control of its related-substance and degradation-product profile by HPLC, robust aseptic filling of an aqueous solution into ampoules with verified container-closure integrity, and tender-ready dossier support for a product procured largely through hospital-formulary, cardiology and ministry-of-health channels. It starts with the active — pharmacopoeial-grade meldonium dihydrate sourced from qualified, audited API makers, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production.
Formulation, filling and sealing then have to preserve both the assay and the dose. The bulk solution is compounded in water-for-injection at controlled pH, sterile-filtered through 0.22 µm membrane and filled aseptically into ampoules under ISO Class 5 air. The filling and sealing parameters are locked in the master batch record, because for a parenteral cardiometabolic agent the assay and the degradation-product profile govern both the efficacy and the safety of every ampoule. Each ampoule is fusion-sealed and 100 % inspected for particulate matter, fill volume, seal quality and cosmetic defects; in-process and release testing confirm meldonium assay by validated HPLC, the related-substance profile, pH, clarity of the solution, and endotoxin is held well within limits so the injection is safe for intravenous or intramuscular administration.
Quality Systems Behind Every Meldonium Injection
Every Farbe Firma Meldonium Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of meldonium against pharmacopoeial reference standards, control of related substances and degradation products by HPLC, pH and osmolarity, clarity and colour of the solution, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, fill-volume verification and container-closure integrity for the ampoule format. Certificates of analysis are issued with full traceability back to the API lot, the primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, calibrated sterilisation and depyrogenation equipment, validated ampoule filling lines with 100 % inspection, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because meldonium is hygroscopic and its assay and degradation profile drive both efficacy and shelf life, we treat the stability-indicating HPLC assay and the degradation-product result as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions, with ICH Q1B photostability challenge, and the product is protected through appropriate primary and secondary packaging.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Meldonium Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across cardiometabolic, cardiovascular, neurological, anti-infective, critical-care and supportive-care categories. For Meldonium Injection specifically, we supply the 100 mg/mL solution in 5 mL ampoules (500 mg) under WHO-GMP conditions, with country-specific strengths, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the stability-indicating-assay and impurity data package — ready to hand for registration and tender qualification.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics. When a buyer needs Meldonium Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, filling-line slot and shipment plan delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the filling suite; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, stability-indicating assay development, related-substance and degradation control, pH and tonicity, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a parenteral cardiometabolic agent given to patients with compromised cardiac or cerebral circulation, where assay accuracy and impurity control directly govern both effect and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Meldonium Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Meldonium Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified ampoule filling lines, qualified water-for-injection systems, 100 % ampoule inspection and continuous environmental monitoring.
Which strengths and pack sizes of Meldonium Injection do you supply?
Our standard presentation is a 100 mg/mL sterile aqueous solution in 5 mL ampoules (500 mg). Custom strengths, fill volumes, ampoule counts per pack and country-specific artwork are available under contract manufacturing agreements.
Can Farbe Firma support country-specific registrations for Meldonium Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
How does Farbe Firma assure the quality and safety of Meldonium Injection?
We control the assay and related substances by stability-indicating HPLC against pharmacopoeial standards, verify pH, clarity and colour, hold endotoxin well within limits by LAL, run particulate and sterility testing, 100 %-inspect every ampoule, verify container-closure integrity, and qualify each batch against ICH Q1A and ICH Q1B protocols.
What is the minimum order quantity for Meldonium Injection contract manufacturing?
MOQs vary by ampoule size, fill volume, label complexity and dossier requirements. For our ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments